A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients
Clinical trial NCT07722767 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07722767
- Sponsor
- Cullinan Therapeutics Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-15
- Primary completion
- 2027-09-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.